Trial Outcomes & Findings for Coping Skills Training for Adolescents With Fibromyalgia (NCT NCT00086047)

NCT ID: NCT00086047

Last Updated: 2017-09-20

Results Overview

Functional disability score is measured by the Functional Disability Inventory (FDI)which assesses ability to engage in usual physical, social and recreational activities. Scores range from 0=no disability to 60 = extreme disability and and are interpreted as No/Mild disability (0-12); Moderate Disability (13-29) and Severe Disability (30-60)

Recruitment status

COMPLETED

Study phase

PHASE3

Target enrollment

114 participants

Primary outcome timeframe

Baseline and 6 months (end of study)

Results posted on

2017-09-20

Participant Flow

Patients diagnosed with juvenile fibromyalgia (ages 11-18 years)were recruited from four pediatric rheumatology clinics in the Midwestern United States.

Patients were screened to determine eligibility for the study. if they met eligibility criteria, they were enrolled in the study and immediately randomized to one of the treatment arms.

Participant milestones

Participant milestones
Measure
Coping Skills
Patients will receive 8 weeks of behavioral training in pain coping strategies
Education
Patient will receive 8 weekly sessions of education about fibromyalgia syndrome.
Overall Study
STARTED
57
57
Overall Study
COMPLETED
50
50
Overall Study
NOT COMPLETED
7
7

Reasons for withdrawal

Reasons for withdrawal
Measure
Coping Skills
Patients will receive 8 weeks of behavioral training in pain coping strategies
Education
Patient will receive 8 weekly sessions of education about fibromyalgia syndrome.
Overall Study
Lost to Follow-up
7
6
Overall Study
Physician Decision
0
1

Baseline Characteristics

Coping Skills Training for Adolescents With Fibromyalgia

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Coping Skills
n=57 Participants
Patients will receive 8 weeks of behavioral training in pain coping strategies
Education
n=57 Participants
Patient will receive 8 weekly sessions of education about fibromyalgia syndrome.
Total
n=114 Participants
Total of all reporting groups
Age, Categorical
<=18 years
57 Participants
n=5 Participants
57 Participants
n=7 Participants
114 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Continuous
15.2 years
STANDARD_DEVIATION 1.8 • n=5 Participants
14.9 years
STANDARD_DEVIATION 1.7 • n=7 Participants
15.0 years
STANDARD_DEVIATION 1.8 • n=5 Participants
Sex: Female, Male
Female
54 Participants
n=5 Participants
51 Participants
n=7 Participants
105 Participants
n=5 Participants
Sex: Female, Male
Male
3 Participants
n=5 Participants
6 Participants
n=7 Participants
9 Participants
n=5 Participants
Region of Enrollment
United States
57 participants
n=5 Participants
57 participants
n=7 Participants
114 participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline and 6 months (end of study)

Population: Intent to treat analysis

Functional disability score is measured by the Functional Disability Inventory (FDI)which assesses ability to engage in usual physical, social and recreational activities. Scores range from 0=no disability to 60 = extreme disability and and are interpreted as No/Mild disability (0-12); Moderate Disability (13-29) and Severe Disability (30-60)

Outcome measures

Outcome measures
Measure
Coping Skills Training
n=57 Participants
Consists of training in pain management skills using cognitive-behavioral therapy techniques
Fibromyalgia Education
n=55 Participants
Consists of education about fibromyalgia and its management
Change in FDI (Functional Disability Inventory) Scores at End of Study
Baseline FDI Score
21.4 units on a 0-60 scale
95% Confidence Interval 9.4 • Interval 18.9 to 23.9
19.2 units on a 0-60 scale
95% Confidence Interval 8.2 • Interval 17.0 to 21.3
Change in FDI (Functional Disability Inventory) Scores at End of Study
End of Study FDI Score
13.4 units on a 0-60 scale
95% Confidence Interval 8.9 • Interval 10.9 to 15.9
17.0 units on a 0-60 scale
95% Confidence Interval 10.5 • Interval 14.0 to 19.9

SECONDARY outcome

Timeframe: 9 weeks and 6 months

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 9 weeks and 6 months

Outcome measures

Outcome data not reported

Adverse Events

Coping Skills

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Education

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Susmita Kashikar-Zuck, PhD

Cincinnati Children's Hospital Medical Center

Phone: 513 636 6337

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place